New York, NY -- (SBWIRE) -- 05/03/2021 -- Fiducial Markers Market Size – USD 90.6 Million in 2019, Industry Growth - CAGR of 4.3%, Industry Trends – Increasing investment in cancer research

The global fiducial markers market is expected to reach USD 127.3 Million by 2027, according to a new report by Reports and Data. Fiducial markers find usage in image-guided radiotherapy procedures, where the placement of the markers is by modalities such as computed tomography (CT) or ultrasound, among others, and may encompass the application of an endoscope. Fiducial markers assist in precisely locating a tumor, thereby allowing the radiologist or a team of radiologists to provide the maximum radiation dosage to the tumor while mitigating the dose radiation imparted to healthy tissue in the vicinity.

The growing prevalence of cancer is a significant factor in driving the fiducial markers market growth. Cancer has a significant impact on global society, including the US. Detection of the disease at an early stage significantly increases the chances of survival. Creating awareness to encourage early diagnosis and screening are the crucial steps responsible for early detection of the disease. Identifying likely warning symptoms of the disease and taking rapid measures is necessary for early diagnosis. Greater awareness of probable symptoms of cancer amongst physicians, nurses, and other healthcare providers, in addition to the general public, would positively impact the survival rate and hence would be instrumental in increasing the market demand. The American Cancer Society proposes that in 2020, over 1.8 million individuals are likely to be diagnosed with cancer, of which various patients would require a blood transfusion, occasionally on a daily basis.

Additionally, a growing inclination towards fiducial markers in stereotactic radiosurgery is of significant importance in propelling the market growth. Stereotactic surgery is a form of minimally invasive surgical technique used to treat functional defects and small tumors of the brain. This minimally invasive surgery is meant especially for those patients having tumors and abnormalities that are hard to reach, subject to movement within the body, or located close to vital organs and anatomic regions.

Request a Sample Copy of the Research Report @ https://www.reportsanddata.com/sample-enquiry-form/3471

Leading Players Profiled in the Report Include:

Boston Scientific Corporation, Naslund Medical AB, Carbon Medical Technologies, Stellar Medical, CIVCO Radiotherapy, Medtronic, Innovative Oncology Solutions, IZI Medical Products, Nanovi A/S, and Eckert & Ziegler, among others.

COVID-19 Impact

As the global economies are experiencing the negative impact of the Covid-19 pandemic, organizations are suffering losses, among various other challenges. Nevertheless, firms in the pharmaceutical industry are of immense importance in combatting the pandemic and are witnessing positive growth in the contagious disease landscape with the race for treatment approval therapy gaining momentum. Patients presently taking cancer therapy or Individuals with active cases may possess different risk profiles associated with contracting COVID-19 and peril of complications arising out of infection from the virus. Cancer patients may suffer from an impaired immune system based on type, treatment approach, age, and various other health-related factors, thereby creating a growing demand for fiducial markers.

Further key findings from the report suggest

By type, metal-based markers contributed to the largest fiducial markers market size in 2019. Metal-based markers such as gold fiducial markers find widespread application owing to the offering of benefits like a high contrast level and better visualization.

By modalities, ultrasound is likely to grow at a rate of 4.7% in the forecast period for the fiducial markers market, attributed to a lower level of toxicity associated with ionizing radiation, as well as cost-effectiveness as compared to other forms of modalities.

By cancer type, lung cancer is likely to witness a growth rate of 4.8% in the forecast period for the fiducial markers market. It may occur due to various reasons, including smoking, genetic, and exposure to toxic gases. The American Cancer Society projects over 228,000 lung cancer cases, with the occurrence of the disease being higher in men than women. It is a significant cause of death in both US men and women dying due to cancer.

The fiducial markers market in the Asia Pacific region is expected to grow at the fastest rate of 5.5% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.

In December 2019, IZI Medical Products, LLC, a leading fiducial markers market player, made an announcement about the acquisition of RadioMed, the producer of VISICOIL™, an implantable fiducial marker.

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/3471

For the purpose of this report, Reports and Data have segmented the global fiducial markers market on the basis of type, modalities, application, end-user, and region:

Type Outlook (Revenue, USD Million; 2017-2027)

Metal-Based Markers
Polymer-Based Markers
Others

Modalities Outlook (Revenue, USD Million; 2017-2027)

Computed Tomography/Computer-Based Computed Tomography
Magnetic Resonance Imaging
Ultrasound
Radiotherapy

Application Outlook (Revenue, USD Million; 2017-2027)

Prostate cancer
Lung Cancer
Breast Cancer
Gastric Cancer
Others

End-User Outlook (Revenue, USD Million; 2017-2027)

Hospitals
Radiotherapy Centers
Academic & Research Centers

Regional Outlook (Revenue, USD Million; 2017-2027)

North America
US
Canada
Europe
Germany
UK
France
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of Asia Pacific
Latin America
Brazil
Rest of Latin America
MEA
Saudi Arabia
UAE
Rest of the Middle East and Africa

Request for Customization @ https://www.reportsanddata.com/request-customization-form/3471

Table of contents           

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Fiducial Markers Segmentation & Impact Analysis

    4.1. Fiducial Markers Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Rising occurrence of cancer

                    4.2.2.2. Increasing investment in cancer research

                    4.2.2.3. Technological advancements

          4.2.3. Market restraints analysis

                    4.2.3.1. Cost prohibitive markers

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. ETOP Analysis

    4.6. Porter's Five Forces Analysis

    4.7. Competitive Metric Space Analysis

    4.8. Price trend Analysis

    4.9. Customer Mapping

    4.10. Covid-19 Impact Analysis

    4.11. Global Recession Influence

……..

Chapter 10. Competitive Landscape

    10.1. Market Revenue Share by Manufacturers

    10.2. Manufacturing Cost Breakdown Analysis

    10.3. Mergers & Acquisitions

    10.4. Market positioning

    10.5. Strategy Benchmarking

    10.6. Customer Mapping

    10.7. Vendor Landscape

 

Chapter 11. Company Profiles

    11.1. Boston Scientific Corporation

          11.1.1. Company Overview

          11.1.2. Financial Performance

          11.1.3. Technology Insights

          11.1.4. Strategic Initiatives

    11.2. Naslund Medical AB

          11.2.1. Company Overview

          11.2.2. Financial Performance

          11.2.3. Technology Insights

          11.2.4. Strategic Initiatives

    11.3. Carbon Medical Technologies

          11.3.1. Company Overview

          11.3.2. Financial Performance

          11.3.3. Technology Insights

          11.3.4. Strategic Initiatives

Continued…….

Have Any Query? Ask Our Experts @ https://www.reportsanddata.com/speak-to-analyst-form/3471

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.